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Abstract.  Microtubules (MTs) have been implicated to 
function in the change of cell shape and intracellular 
organization that occurs during myogenesis. However, 
the mechanism by which MTs are involved in these 
morphogenetic events is unclear. As a first step in 
elucidating the role of MTs in myogenesis, we have 
examined the accumulation and subcellular distribution 
of posttranslationally modified forms of tubulin in 
differentiating rat ~  muscle cells, using antibodies 
specific for tyrosinated (Tyr), detyrosinated (Glu), and 
acetylated (Ac) tubulin.  Both Glu and Ac tubulin are 
components of stable MTs, whereas Tyr tubulin is the 
predominant constituent of dynamic MTs.  In prolifer- 
ating ~  myoblasts, as in other types of proliferating 
cells, the level of Glu tubulin was very low when com- 
pared with the level of Tyr tubulin.  However, when we 
shifted proliferating L  cells to differentiation media, 
we observed a rapid accumulation of Glu tubulin in 
cellular MTs.  By immunofluorescence, the increase in 
Glu tubulin was first detected in MTs of prefusion myo- 
blasts and was specifically localized to MTs that were 
associated with elongating portions of the cell. MTs in 
the multinucleated myotubes observed at later stages of 
differentiation maintained the elevated level of Giu 
tubulin that was observed in the prefusion myoblasts. 
When cells at early stages of differentiation (<1  d after 
switching the culture medium) were immunostained 
for Glu tubulin and the muscle-specific marker, mus- 
cle myosin, we found that the increase in Glu tubulin 
preceded the accumulation of muscle myosin. Thus, 
the elaboration of Glu MTs is one of the very early 
events in myogenesis. Ac tubulin also increased during 
L  myogenesis; however, the increase in acetylation 
occurred later in myogenesis, after fusion had already 
occurred. Because detyrosination was temporally cor- 
related with early events of myogenesis, we examined 
the mechanism responsible for the accumulation of 
Glu tubulin in the MTs of prefusion myoblasts. We 
found that an increase in the stability of I~ cell MTs 
occurred at the onset of differentiation, suggesting that 
the early increase in detyrosination that we observed 
is a manifestation of a decrease in MT dynamics in 
elongating myoblasts. We conclude that the establish- 
ment of an oriented array of microtubules heightened 
in its stability and its level of posttranslationally 
modified subunits may be involved in the subcellular 
remodeling that occurs during myogenesis. 
T 
HE differentiation  of myoblasts in tissue culture is a 
complex process,  involving dramatic changes in gene 
expression, transcription of new muscle-specific mes- 
sages,  and accumulation of myofibriUar proteins.  In addi- 
tion, cultured myoblasts undergo significant morphological 
changes during myogenesis; they assume an elongated shape, 
neighboring cells align in an appropriate  orientation, and 
myoblasts eventually fuse with their neighbors to form mul- 
tinucleated myotubes. Although a wealth of  experimental de- 
tail is available concerning transcription  and translation  of 
muscle-specific gene products (Devlin and Emerson, 1978; 
Zevin-Sonkin and Yaffe, 1980; Minty et al.,  1982) and fu- 
sion of myoblasts (Kalderon and Gilula,  1979; Senechal et 
al., 1982), the cellular factors responsible for morphogene- 
sis during myogenesis are not yet well understood. 
Dramatic alterations  in the cytoskeleton  are commonly 
thought to evoke morphogenetic events, and there is circum- 
stantial evidence in support of the idea that the cytoskeleton 
is involved in the morphogenetic  events of myogenesis. Early 
investigators showed microtubules (MTs),' along with inter- 
mediate filaments and stress  fibers,  coursing through the 
cytoplasm parallel to the long axis of both elongating myo- 
blasts and postfusion myotubes (Okazaki and Holtzer, 1965; 
Fischman, 1970). MTs, specifically, have been implicated in 
myogenesis by virtue of their close juxtaposition  to forming 
myofibrils (Warren,  1974) and by the effects of MT antago- 
nists upon the differentiation of muscle cells. Both prefusion 
myoblasts and differentiated  myotubes are altered in their 
I. Abbreviations used in this paper: Ac MT, microtubule enriched in ace- 
tylated alpha-tubulin; Ac tubulin; aeetylated alpha-tubulin; Glu MT, micro- 
tubule enriched in detyrosinated alpha-tubulin; Giu tubulin, detyrosinated 
alpha-tubulin; MHC, myosin heavy chain; MT, microtubule; TTL, tubulin 
tyrosine ligase; Tyr MT, microtubule enriched in tyrosinated alpha-tubulin; 
Tyr tubulin, tyrosinated alpha-tubulin. 
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when cytoplasmic MTs are disrupted by MT-depolymerizing 
agents (Ishikawa et al.,  1968;  Toyama et al.,  1982).  Simi- 
larly, the MT-stabilizing compound, taxol, disrupts myogen- 
esis in cultured cells, yielding cells with aberrantly formed 
myofibrils (Antin et al.,  1981; Toyama et al.,  1982). 
While it is clear that the integrity of the MT array is re- 
quired for normal myogenesis, the precise  role played by 
MTs in effecting myogenesis is unknown. MTs seem to par- 
ticipate in two distinct events in the myogenic program: the 
elongation and alignment of myoblasts before their fusion 
into syncytial myotubes and the formation of myofibrils with- 
in the myotubes. Perhaps the better accepted of these is the 
organizing activity that MTs exhibit in the formation and or- 
ganization of myofibrils.  When myogenic cells are treated 
with taxol, actin-containing thin filaments do not form, while 
myosin-containing thick filaments align, instead, along the 
stabilized MTs (Antin et al., 1981; Toyama et al., 1982). This 
result suggests that within developing myotubes the MTs serve 
as "templates; which are depolymerized  and replaced by thin 
filaments to generate the characteristic myofibrillar array of 
mature myotubes. 
A role for MTs earlier in the myogenic program, during 
the cell elongation and alignment phase, has not been dem- 
onstrated directly. However,  by inference from other mor- 
phogenetic systems in which there is pharmacological evidence 
that MTs are involved in cell shape changes (for a considera- 
tion of numerous examples see Dustin, 1984), one would pre- 
dict a similar involvement of MTs in myoblast elongation and 
alignment. In fact, during myoblast elongation, the radially 
based MT array, with MTs centered at the centrosomes, be- 
gins to change to the more elongated, bipolar array that is 
ultimately observed in syncytial myotubes (Warren,  1974; 
Tassin et al., 1985). In myotubes, the MTs ultimately emanate 
from multiple sites around the periphery of the nuclei. While 
this change from a radial, centrosomal array of MTs to a bi- 
polar, nuclear array of MTs is a characteristic feature of myo- 
genesis, it is a postfusion alteration and, therefore, cannot 
function in the early morphogenetic events of myoblasts. 
Of the mechanisms that might be involved in modulating 
MT function during the earliest stages of myogenesis, we 
chose to focus on posttranslational modifications of tubulin 
since, overall, the changes in MT arrays that are effected by 
posttranslational modification are relatively rapid when com- 
pared with other modulators of MT function; e.g., the differ- 
ential expression of tubulin isoforms (Fulton and Simpson, 
1976; Cleveland and Sullivan, 1985; Villesante et al., 1986) 
or of microtubule-associated proteins (Vallee, 1984; Olmsted, 
1986). Two posttranslational modifications of tubulin, tyro- 
sination and acetylation, are known to yield coexisting tubu- 
lin species that may be functionally distinct (Gundersen et 
al., 1984; Piperno et al., 1987). In fact, tyrosination/detyro- 
sination, in which the COOH-terminal tyrosine of alpha-tu- 
bulin is reversibly removed (Barra et al., 1974; Argarafia et 
al., 1978), has been studied during several types of morpho- 
genetic and differentiative events; alterations in the level of 
the enzyme that carries out tyrosination or in the level of 
tyrosinated alpha-tubulin (q~yr tubulin) have been temporally 
correlated with both neural (Rodriguez and Borisy,  1978; 
Deanin et al., 1977) and muscle (Deanin et al., 1977) devel- 
opment. Localization of the Tyr tubulin and detyrosinated 
alpha-tubulin (Glu tubulin) with specific antibodies has shown 
that most MTs in interphase cultured cells contain predomi- 
nantly Tyr tubulin while a small subset of MTs is enriched 
in Glu tubulin (Glu MTs) (Gundersen et al., 1984; Gunder- 
sen and Bulinski, 1986;  Geuens et al.,  1986; Kreis,  1987; 
Wehland and Weber,  1987).  Glu MTs arise by a postpoly- 
merization modification  of  preexisting MTs composed of Tyr 
tubulin (Tyr MTs) (Gundersen et al.,  1987); thus, Glu MTs 
are those that were polymerized less recently than Tyr MTs. 
In fact, in one study, Glu MTs were found to persist for at 
least 16 h, possibly throughout an entire cell cycle (Webster 
et al., 1987b). The dynamics ofGlu MTs are in striking con- 
trast with the dynamics of most cellular MTs (hence, Tyr 
MTs),  whose half-time of depolymerization is  5-10  min 
(Schulze and Kirschner, 1986). While the function of stable, 
Glu MTs has not been identified, evidence obtained from 
3T3 fibroblasts suggests that Glu MTs may be important for 
the determination of  cell polarity; in 3T3 cells induced to un- 
dergo directed cell migration, an oriented array of Glu MTs 
is established during the cell polarization that occurs before 
the commencement of active cell migration (Gundersen and 
Bulinski, 1988). 
Another posttranslational modification of alpha-tubulin 
has been described in which the epsilon-amino group of ly- 
sine 40  is  acetylated (L'Hernault and  Rosenbaum,  1985; 
LeDizet and Piperno, 1987).  The existing information con- 
cerning acetylation argues that this modification is mecha- 
nistically distinct from detyrosination, although the two mod- 
ifications share some features. For example, in most types 
of interphase cells in culture, a subset of MTs contains seg- 
ments enriched in acetylated alpha-tubulin (Ac tubulin) (Pi- 
perno et al., 1987; Bulinski et al.,  1988);  in cells in which 
both acetylation and detyrosination are detectable, the sub- 
sets of MTs enriched in Glu and Ac tubulin (called Glu and 
Ac MTs, respectively), are nearly coincident (Bulinski et al., 
1988). Similarly, acetylation of alpha-tubulin has been shown 
to increase during developmental events such as neurite out- 
growth (Black and Keyser, 1987; Sale et al., 1988). Ac tubu- 
lin, like Glu tubulin, is enriched in vivo in stabilized MTs 
(Piperno et al.,  1987; Webster and Borisy,  1989). 
In this paper, we have characterized the alterations of tubu- 
lin posttranslational modification that accompany myogene- 
sis  in cultured I_.6 cells.  We also demonstrate a  dramatic 
change in MT dynamics that occurs early in myogenesis and 
present evidence suggesting that the stabilization of an array 
of MTs in myoblasts brings about their increased posttransla- 
tional modification. We propose that stable MTs oriented 
within elongating myoblasts may be involved in the morpho- 
logical and differentiative changes of myogenesis. 
Materials and Methods 
Cell Culture 
Except as noted, all tissue culture chemicals and solutions were obtained 
from Gibco Laboratories (Grand Island, NY). The L6 myogenic line, orig- 
inally isolated from rat muscle tissue by Yaffe (1968),  was obtained from 
American Type Culture Collection (CRL 1458;  Rockville, MD). I..6 cells 
were grown on 100-ram plastic tissue culture dishes or on glass coverslips. 
The growth medium used consisted of DME supplemented with 10% FBS 
(HyClone Laboratories, Logan, UT). In the differentiation medium, the se- 
rum was replaced with 3% equine serum (Flow Laboratories, Inc., McLean 
VA; equine serum used was heat inactivated at 50°C for 30 rain). In general, 
proliferating  I-,6 cells were fed every other day and passnged (releasing them 
from the dish with Viokase) or differentiated when subconfluent. Differenti- 
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Indirect lmmunofluorescence 
Indirect immunofluorescence of Glu, Tyr, and Ac tubulin was performed 
on methanol-fixed  cells as previously described (Bulinski et al., 1988). Rab- 
bit polyclonal antibodies to Tyr and Glu tubulin (Gundersen et al.,  1984) 
were used as 2 and 1% solutions, respectively, diluted in PBS or directly 
in Ac tubulin antibody (6-11-B1; a hybridoma supernatant kindly provided 
by Dr. Gianni Piperuo, Rockefeller University, New York).  Total cellular 
tubulin was detected using a  1%  solution of an aseites fluid of a  mouse 
monoclonal antibody reactive with beta-tubulin (3F3; the generous gift of 
Dr. James Lessard,  University of Cincinnati, Cincinnati, OH).  Muscle- 
specific myosin heavy chain (MHC) was detee~l in the fixed I-,6 ceils using 
a  1:10 dilution of a mouse hybridoma supernatant (MF20; kindly provided 
by  Dr.  D.  Fischman, Cornell University Medical College,  New York). 
Fluorescein-conjugated goat  anti-mouse antibodies  (diluted  1:50)  were 
used to visualize primary antibodies to myosin and to total tubulin; other 
secondary antibodies were used as described (Bulinski et al.,  1988). 
Iramunoblots 
Western blots were performed and analyzed as previously described (Bulin- 
ski et al.,  1988);  blots stained for total beta-tubulin were incubated with a 
1:2,000 dilution of 3F3 ascites fluid and processed analogously to the others. 
Total protein was determined with the modified Lowry assay of Creiger and 
Bessman (1972) or, for SDS samples, the procedure of Tornqvist and Bel- 
frage (1976). 
Assay of Tubulin ~yrosine Ligase (TTL) 
TTL  activity  was determined using the assay  procedure of Flavin and 
Mumfushi (1984).  Thrice-cycled bovine brain microtubule protein, purified 
as described by Vallee (1986)  was used as the substrate in our assay.  Cell 
extracts to be assayed were prepared as follows, with all steps carried out 
at 0--4°C: four 100-ram culture dishes (per time point) were washed twice 
with ligase stabilization buffer (25 mM morpholino ethane sulfonic acid, pH 
6.8, 0.1 M KCI, 2 mM MgCl2, 1 mM EGTA, 1 mM ATE 1 mM DTT) and 
then once with the same buffer to which 20% glycerol and 0.2 mM PMSF 
had been added. Next, the cells were collected with a rubber policeman in 
0.5-1 ml of the latter buffer and briefly homogenized with a motor-driven 
teflon and glass homogenizer. The homogenate was clarified by centrifuga- 
tion (45 min at 40,000 rpm at 4"C in a type 65 rotor [Beckman Instruments, 
Inc., Fullerton, CA]). The supernatant was assayed immediately, although 
we found that storage at -80°C for up to 2 wk did not diminish the TTL 
activity. 
Results 
The rat L~ myogenic line is a valuable model for the in vitro 
study of myogenesis. As shown in Fig. 1, upon changing the 
medium bathing the L6 myoblasts from growth medium to 
differentiation medium,  myogenesis ensued rapidly; cells 
first became elongated and aligned, and fusion commenced 
on day 1. Striated myofibrils began to appear on day 4 and 
began to show contractile behavior on day 8. We observed 
only slight variation in the kinetics of fusion from experiment 
to experiment (see error bars in Fig. 1). This uniformity and 
final high level  of myogenic differentiation made 1.~ cells 
amenable to the assay of tubulin forms in populations of cells 
at various stages of differentiation. 
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ation of I.~ cultures was measured by determining the percentage of nuclei 
that were found in muitinucleated cells; for each time point, a total of 2,000 
nuclei per dish were scored from random fields. 
We assessed the stability of MTs during myogenesis by treating I-,6 cells 
with the mierotubule antagonist, nocodazole (Aldrich Chemical Co., Mil- 
waukee, WI). Cells were exposed to 10 #M nocodazole (added directly to 
the culture medium from a 5 mM stock solution in DMSO) for 6 or 25 rain. 
Drug-treated cells were then extracted for 1 min with 0.6% Triton X-100 
(Sigma Chemical Co., St. Louis, MO) in an MT-stabilizing buffer, essen- 
tially as described previously (Khawaja et al., 1988),  to reduce the diffuse 
staining contributed by monomeric tubulin. 
~gure 1. Tune course of L6 cell myogenesis.  [,6 cells were switched 
to differentiation  medium at day 0, and the extent of myoblast  fusion 
(% fusion) was defined as the percentage of nuclei in the culture 
that were found in multinucleated myotubes. 2,000 nuclei were 
counted for each time point; data represent the mean ±  SD from 
three separate experiments. 
Alterations in Posttranslational Detyrosination of 
Tubulin during Myogenesis 
To determine whether any change in posttranslational dety- 
rosination occurred during the morphogenetic events of  myo- 
genesis, we compared the distribution of Tyr tubulin in 1,6 
cells (Fig. 2, b, e, h, and k) with that of total tubulin (data 
not shown), and Glu tubulin (Fig. 2, a, d, g, and j) at each 
stage of L6 cell differentiation. At all stages, the distribution 
of Tyr tubulin mimicked that of total tubulin; thus, our results 
on the distribution ofTyr tubulin during myogenic differenti- 
ation resembled results obtained previously by others on the 
distribution of tubulin during myogenesis (Warren,  1974; 
Tassin et al.,  1985).  Before differentiation, the distribution 
ofTyr MTs in mononucleated myoblasts is similar to that ob- 
served in many types of undifferentiated cultured cells. Tyr 
MTs are focused at the centrosome, which is located near the 
nucleus, and extend throughout the myoblast cytoplasm to the 
cell periphery (Fig. 2, b and c). The relative flatness of the 
myoblasts is advantageous for immunofluorescence; some 
MTs can be traced from the cell margin almost all of the way 
back to the centrosome. As cells elongate and align for fusion, 
the Tyr MT array becomes oriented parallel to the long axis 
of the cell (Fig. 2, e and f). After fusion, the l.~ cells remain 
flat, such that distinct MTs can still be visualized by Tyr tu- 
bulin antibody staining along the length of  the myotubes, par- 
allel to the nascent myofibrils (Fig. 2, h and i). As previously 
reported by Tassin et al. (1985),  at this stage of myogenesis 
MTs no longer appear to be organized by the centrosome. At 
later stages of myogenic development (e.g., at day 11; Fig. 
2 k), we observed grainy, indistinct immunofluorescent stain- 
ing with the Tyr tubulin antibody. This grainy pattern of tu- 
bulin staining, which was also obtained with other anti-tubu- 
lin antibodies, was unchanged in cells that were extracted 
with detergent to remove monomeric tubulin, suggesting that 
the grainy staining is attributable to polymeric tubulin within 
the myotubes (data not shown). Presumably, the density of the 
myofibrillar proteins in some regions of the cells rendered 
the immunofluorescent  staining of MTs grainy and indistinct. 
Gundersen et al.  Generation of Stable Microtubules during Myogenesis  2277 Figure 2.  Immunofluorescence distribution of Giu and Tyr tubulin during myogenesis. L~ cells at days 0 (a-c),  1 (d-f), 4 (g-i), and 11 
(j-l) of  myogenesis are shown; for each time point, the distribution  ofGlu (a, d, g, and  j) and Tyr tubulin (b, e, h, and k) and the correspond- 
ing phase image are shown. Arrow in d indicates an elongated myoblast with virtually all MTs stained with the Glu tubulin antibody; arrow- 
head in g  indicates an unfused myoblast amongst fused myotubes. Bar,  15 #m. 
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Figure 3. Appearance of muscle- 
specific MHC and Glu MTs dur- 
ing  the early stages of 1-.6 cell 
myogenesis. Double immunoflu- 
orescent labeling was used to de- 
tect  muscle-specific  MHC  (m) 
and  Glu  MTs (o)  in  myoblasts 
differentiated for the indicated in- 
tervals. Data was obtained from 
300-500 cells  in  random  fields 
for each time point. Data are ex- 
pressed  as  the  average of three 
separate determinations  :t: SD 
Glu tubulin appeared from immunofluorescent staining to 
constitute only a minor species in myoblasts; in only *20% 
of the myoblasts were Mrs deteetably stained with the Glu 
tubulin antibody, and in these cells only a small number of 
MTs were brightly labeled (Fig.  2 a).  Western blotting of 
l_~ cell extracts and brain tubulin standards with the Tyr and 
Glu tubulin antibodies confirmed that only a small propor- 
tion of the tubulin in myoblasts was detyrosinated (data not 
shown). Thus, both the distribution and level of Tyr and Glu 
tubulin in rnyablasts are similar to that observed in many other 
types of proliferating cells (Gundersen et al., 1984; Gunder- 
sen and Bulinski,  1986; Geuens et al.,  1986; Wehland and 
Weber,  1987;  Kreis,  1987). 
In contrast to the situation in proliferating myoblasts, we 
observed a dramatic increase in the level of Glu tubulin dur- 
ing myogenic differentiation. Even on day 1 after switching 
to differentiation medium, the L  cells showed a significant 
increase in the number of MTs that stained with the Glu tubu- 
lin antibody (Fig. 2, d-f).  These day-1 cultures were com- 
posed predominantly of unfused myoblasts (Fig.  1 and Fig. 
2 c); thus, it is clear that the increase in the number of Glu 
MTs occurred before actual myoblast fusion (also see be- 
low). In fused myotubes, which were first observed in day-1 
cultures,  we consistently found high levels of Glu tubulin 
staining. In fact, as is shown for myotubes in day-4 (Fig. 2, 
g-i) and day-11 (Fig, 2,j-l) cultures, virtually all of the MTs 
were brightly stained with the Glu tubulin antibody. Some 
graininess in the staining with Glu tubulin antibody, analo- 
gous to that observed with the Tyr or total tubulin antibodies, 
was  observed in  myotubes from  long-term cultures  (Fig. 
2j). 
As described above, we found that an increase in Glu MT 
staining occurred before myoblast fusion. To more accurately 
pinpoint the timing of this change, we examined cultures of 
L6 cells that had been switched to differentiation medium 
for x<l d. During the first day of myogenesis (from day 0 until 
day 1), the number of myoblasts that exhibited distinctly la- 
beled Glu MTs increased from 22 to 60% (Fig. 3). Increased 
Glu tubulin staining was also manifested as an increase in the 
number of Glu MTs present in each myoblast; in fact, in the 
60 % of the myoblasts that exhibited Glu MTs on day 1, the 
number of Glu MTs in each cell was higher than in any myo- 
blast at day 0 (e.g., compare Fig 2 a  with d). Finally, in a 
significant proportion of day-1 myoblasts (~15%; Fig. 2 d, 
arrow),  virtually all of the MTs were stained with the Glu 
tubulin antibody, a level of staining similar to that detected 
in fused myotubes. We have confirmed that the increases in 
Glu tubulin staining apparent from immunofluorescence as- 
says correspond to actual increases in the level ofGlu tubulin 
measured by quantitative immunoblotting (see below). 
The results described above show that the increase in Glu 
MT staining occurs at an early, prefusion stage of myogene- 
sis. To relate the timing of the increase in Glu tubulin to other 
well-characterized myogenic events, we correlated the tim- 
ing of increased Glu MT staining with two prefusion markers 
of myogenic differentiation: the acquisition of an elongated 
morphology and the accumulation of muscle-specific MHC 
(Clegg et al.,  1987). As rapidly as 6 h after the ~  cells had 
been switched to differentiation medium, we observed an in- 
crease in the number of cells exhibiting Glu MT staining (Fig. 
3). This increase in Glu MT staining was almost always as- 
sociated with myoblasts that possessed an elongated morphol- 
ogy, and the Glu MTs were frequently localized to the ex- 
tended areas of the cell (Fig. 4).  Cells that maintained an 
unextended morphology never exhibited the high levels of Glu 
tubulin staining observed in elongated cells, although some 
of them did contain a small number of randomly distributed 
Glu MTs (Fig. 4). 
As a second marker of early myogenic differentiation, we 
examined the accumulation of muscle-specific MHC.  Ac- 
cumulation of immunologically detectable MHC is frequently 
used as an early marker of myogenic differentiation and is 
known to occur in advance of myoblast fusion (Clegg et al., 
1987). Fig. 5, a and b, shows the Glu tubulin and MHC im- 
munofluorescent staining patterns of 1.6 myoblasts that have 
been in differentiation medium for 24 h. All of the myoblasts 
positive for MHC also exhibit brightly labeled Glu MTs. In 
addition, several cells with labeled Glu MTs, but no detect- 
able MHC staining, can also be seen (Fig. 5, arrows). In fact, 
when we examined cultures that had been switched to differ- 
Gundetsen et al. Generation of Stable Microtubules during Myogenesis  2279 Figure 4. Distribution of Glu MTs in elongating myoblasts. Prefusion L6 myoblasts were stained for (a) total tubulin and (b) Glu tubulin. 
(c) Phase image of the myoblasts shown in a  and b; (d) Glu tubulin immunofluorescent staining (as in a) shown with simultaneous phase 
illumination to show Glu MTs oriented along the length of elongated myoblasts (arrows).  The field of cells included in the micrograph 
contains only myoblasts. Bar,  15/zm. 
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detection of (a) Glu MTs and 
(b)  muscle-specific MHC in 
differentiating myoblasts. L6 
cells 24 h after the switch to 
differentiation  medium  are 
shown; arrows indicate elon- 
gated myoblasts that contain 
detectable Glu MTs but do not 
contain detectable MHC stain- 
ing. Note other myoblasts  that 
contain both Glu tubulin and 
MHC staining. Bar, 15 #m. 
entiation medium for varying intervals, we always found a 
proportion of myoblasts that exhibited brightly labeled Glu 
MTs, but did not contain detectable MHC (Fig. 3). One can 
see from Fig. 3 that the increase in Glu MT staining occurred 
at least 6 h earlier than the increase in MHC staining. The 
sensitivity of detection of Glu tubulin and MHC may be 
different, allowing us to detect the increase in posttransla- 
tionally generated Glu tubulin sooner than the newly accu- 
mulated MHC; nonetheless, our results clearly demonstrate 
that the elaboration ofGlu MTs is one of  the very early events 
of myogenesis. 
Alterations in Posttranslational Acetylation of Tubulin 
during Myogenesis 
The close correlation between the patterns of  Glu tubulin and 
a  second posttranslationally modified form, Ac tubulin, in 
fibroblasts and epithelial cells (Bulinski et al., 1988) prompt- 
ed us to examine the distribution of Ac tubulin during myo- 
genesis. As shown in Fig. 6, the distribution of Ac tubulin 
did change markedly during I_~ cell myogenesis. In prolifer- 
ating myoblasts (day 0 of differentiation), "080  % of the cells 
possessed some Ac tubulin staining. The pattern of Ac tubu- 
lin staining resembled that previously observed in other types 
of proliferating cells (Piperno et al.,  1987; Bulinski et al., 
1988);  that is, segmented staining of a small subset of the 
MTs, with a few continuously labeled MTs in each cell (Fig. 
6 b). Most myoblasts at day 1 after switching cells to differen- 
tiation media were indistinguishable from proliferating cells 
in their Ac tubulin staining pattern (compare Fig. 6, b with 
d); only a small percentage ('07%) of the small myotubes 
present on day 1 showed a significant increase in the level 
of Ac tubulin staining (data not shown). The percentage of 
myotubes brightly stained with Ac tubulin antibody did in- 
crease during later myogenic differentiation; by day 4, 80% 
of the myotubes were Ac tubulin stained; and, of these, 32% 
contained distinct Ac MTs, while the remainder contained 
hazy, indistinct staining (Fig 6f). By day 11, most myotubes 
(92%) showed bright Ac tubulin antibody staining, most of 
which appeared hazy or grainy (Fig 6 h). The pattern of Ac 
tubulin staining was clearly distinct from the pattern of Glu 
tubulin staining, both in prefusion myoblasts and in early 
myotubes (compare Fig. 6, a with b and c with d); however, 
in more mature myotubes the patterns of the two modified 
forms of  tubulin were nearly indistinguishable (compare Fig. 
6, e with f  and g with h). Notably, the timing of the initial 
increases in Glu and Ac tubulin were distinctly different; Glu 
tubulin was already elevated in prefusion myoblasts (Fig 6, 
c and d), while Ac tubulin increased later,  in the more ma- 
ture myotubes (Fig. 6, e-h). 
Quantitative Changes in the Levels of Glu and Ac 
Tubulin during Myogenesis 
To determine quantitatively the changes in Glu and Ac tubu- 
lin levels during myogenesis, we performed a densitometric 
analysis of immunoblots prepared from samples made at var- 
ious intervals after the cells were switched to differentiation 
medium (Fig. 7, a  and b). We found that both total tubulin 
and Tyr tubulin showed a modest increase (,o8-10%) during 
the course of the differentiation. The level of Glu tubulin, 
however,  showed a greater proportional increase; by day 4, 
when ,080%  of the myoblasts had undergone fusion, the 
level of Glu tubulin was approximately five times the level 
in proliferating myoblasts (Fig 7 b). The level of Glu tubulin 
actually decreased slightly during the later stages of myogen- 
esis, during maturation of the myotubes. Despite the large 
proportional increase we observed in the level of Glu tubu- 
lin, Tyr tubulin remained the predominant form of alpha- 
tubulin throughout myogenesis (data not shown). The quan- 
titative immunoblots also showed that the Ac tubulin level 
increased dramatically during myogenesis; in agreement with 
the immunofluorescence  data, this increase occurred later in 
myogenesis, when fusion was largely complete (Fig 7, a and 
b). Unlike Glu tubulin, the level of Ac tubulin continued to 
increase during myotube maturation (Fig 7; day 11). Thus, 
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during L6 myogenesis. Immunofluorescence 
patterns of Glu (a, c, e, and g) and Ac (b, 
d, f  and h) tubulin are shown in L6 cells at 
days 0 (a and b), 1 (c and d), 4 (e and f), 
and  11  (g and  h)  of differentiation.  Bar, 
15/~m. 
for both Glu and Ac mbulin,  the quantitative immunoblot 
data corroborated the immunofluorescence observations and 
showed that the level of each modified form of alpha-tubulin 
underwent distinct temporal changes during myogenesis. 
We noted that Western blots immunostained with the Glu 
tubulin  antibody exhibited  a  second,  weaker band  of im- 
munoreactivity (Fig. 7 a). Because this band migrated as a 
200-kD protein and increased in level during myogenesis, we 
suspected that our Glu tubulin antiserum was cross-reactive 
with muscle-specific MHC. This suspicion was confirmed by 
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(a) Western blots of L~ cell extracts. Extracts were prepared from 
I.~ cells at the indicated stages of differentiation (expressed as the 
number of days [0, 1, 4,  11] after switching the cells to differentia- 
tion medium). Extract protein (48 #g of protein per lane) was elec- 
trophoresed and the gels were transferred to nitrocellulose. Multi- 
ple replicas of these blots were stained for Tyr (lanes a--d), Glu 
(lanes e-h), Ac (lanes i-l), and total tubulin (lanes i-l). Migration 
of alpha- (a) and beta-tubulin (B) and of MHC (MHC) are shown. 
The blot on the right (lanes i-l) was sequentially  stained for Ac 
tubulin and total beta-tubulin,  which can be seen at the alpha- and 
beta-tubulin  positions,  respectively. (b) Relative levels of tubulin 
isotypes during  myogenic differentiation.  Densitometric  scans of 
western blots were used to calculate the level of Tyr, Glu, Ac, and 
total tubulin in differentiating ~  cells, relative to the level in un- 
differentiated myoblasts (at day 0). Data represent mean + SD from 
three experiments. 
blots of MHC standards (data not shown); presumably a se- 
quence within muscle MHC is homologous to the peptide 
with which our Glu tubulin antibody was elicited.  What is 
important for the current study, however, is whether this ad- 
ditional reactivity of the Glu tubulin antibody interfered with 
our analysis of Glu tubulin during myogenesis. Several lines 
of evidence  demonstrate  that  the  cross-reactivity of Glu 
tubulin antibody with MHC did not interfere with any of our 
results.  First, we have used greater than saturating concen- 
trations of Glu tubulin antibody to stain blots, such that we 
have always had enough antibody to saturate the Glu tubulin 
sites (as well as any myosin sites). Second, we have looked 
critically at cells double  stained  for Glu tubulin  and total 
tubulin and confirmed that all Glu tubulin antibody staining 
represents a subset of  the staining with total tubulin antibody. 
Since the total tubulin antibody does not cross react with any 
other cellular proteins we can,  thus,  be sure that the Glu 
tubulin  antibody yields immunofluorescent images of Glu 
tubulin and not of myosin. In particular, note that the grainy 
staining of Glu tubulin in mature myotubes (see Fig. 2j) can 
not be attributed to MHC cross-reactivity of the Glu tubulin 
antibody since we observed identical grainy staining in ma- 
ture myotubes with a variety of other tubulin antibodies that 
do not react with MHC (our Tyr, Ac, and total tubulin anti- 
bodies) and Lewis and Cowan (1988) observed similar pat- 
terns  with  other  tubulin  antibodies.  In  fact,  immunofluo- 
rescent staining of MHC was observed only in a  few very 
well-developed myotubes (data not shown) in which sarco- 
meric staining was apparent with the Glu tubulin antibody 
and not with the other tubulin antibodies. 
Changes in MT Stability during Myogenic 
Differentiation 
In proliferating fibroblasts and epithelial cells in culture, Glu 
MTs have been shown to be generated by the postpolymeriza- 
tion detyrosination of MTs polymerized from a pool of Tyr 
tubulin monomers (Gundersen et al.,  1987).  In these cells 
then, the level of Glu tubulin in an MT serves as an indicator 
of the longevity of the MT. We have performed experiments 
with I~ cells similar to those that established the postpoly- 
merization detyrosination mechanism for fibroblasts and ep- 
ithelial cells and have found that the same postpolymeriza- 
tion mechanism is responsible for generating Glu MTs in 
cells  (data  not  shown).  The postpolymerization model 
predicts that stabilization of dynamic MTs would result in an 
increased level of detyrosination. Therefore, we hypothesized 
that the relative increase we observed in the level of Glu MTs 
might result  from a  stabilization  of myoblast MTs during 
myogenesis. 
To test this hypothesis, we treated myoblasts and myotubes 
with the MT antagonist, nocodazole. Relative resistance to 
nocodazole-induced  depolymerization provides  an  assess- 
ment of MT stability and has been used with other cell types 
to establish the enhanced stability of both Glu and Ac MTs 
(Piperno et al.,  1987;  Wehland and Weber,  1987;  Khawaja 
et al.,  1988). Fig. 8 shows that MTs in undifferentiated myo- 
blasts (in day-0 cultures) were exquisitely sensitive to noco- 
dazole-induced depolymerization; most MTs were disassem- 
bled by a 6-min treatment (Fig.  8, a  and b). With a 25-min 
treatment, MTs were almost entirely disassembled (data not 
shown). We observed similar nocodazole sensitivity for the 
Oundersen eta]. Generation  of Stable Micrombules  during Myogenesis  2283 Figure 8.  Drug-resistance of MTs in differentiating I.,6 cells. Total tubulin distribution (a, c, and e) and phase images (b, d, and f) of 
differentiating cells (on days 0 [a and hi, 1 [c and d] and 4 [e and f]) treated with 10 #M nocodazole for 6 min before processing for im- 
munofluorescence (see Materials and Methods for details). Bar,  15 ~m. 
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subset of the day-1 myoblasts exhibited a significant number 
of MTs that resisted depolymerization during a 6-min noco- 
dazole treatment (Fig. 8, c and d). This subset of myoblasts 
was typically elongated, and the stable MTs in them were, 
for the most part, oriented along the cell's long axis (Fig. 8 
c). Longer trealments with nocodazole (25 min) did not change 
the pattern of stable MTs in elongated day-1 myoblasts; in 
contrast, myoblasts that did not show an elongated morphol- 
ogy were almost completely devoid of MTs after a 25-min 
drug treatment (data not shown). The nocodazole stability of 
MTs in myotubes was similar to that observed in elongated 
myoblasts; numerous MTs were stable to a 6-min nocodazole 
treatment (Fig. 8, e and  f), and increasing the treatment time 
to 25 min had little effect on the array. 
While the cells shown in Fig. 8 were stained with an anti- 
body to total tubulin  (so that all of the  stable MTs were 
identified), in other experiments we double stained nocoda- 
zole-treated cells with the Glu tubulin antibody and the total 
tubulin antibody. As expected from results obtained in other 
cell types (e.g., Khawaja et al., 1988), nearly all of the MTs 
stable to a  long (25 min) treatment with nocodazole were 
stained brightly with the Glu tubulin antibody. These data 
demonstrate that posttranslationally modified MTs in differ- 
entiating prefusion myoblasts and in myotubes are dramati- 
cally more stable to the action of nocodazole than MTs in 
proliferating myoblasts and support the notion that the in- 
creased modification of a subset of MTs during myogenesis 
is the result of their enhanced stability. 
ITL Acffvity during Myogenesis 
While the results described above strongly argue that the in- 
creased detyrosination of tubulin during myogenesis is due 
to  increased  MT  stability,  the  possibility  remained  that 
changes in the level of the modifying enzymes might contrib- 
ute to a change in the cellular level of the Glu tubulin. Two 
cytoplasmic enzymes, TTL (Raybin and Flavin, 1977; Flavin 
and  Murofushi,  1984)  and tubulin  carboxypeptidase (Ar- 
garafia et al.,  1978, 1980), are involved in tyrosinating and 
detyrosinating cellular tubulin, respectively. Because of in- 
sufficient characterization of the tubulin carboxypeptidase 
and the presence of lysosomal enzymes that mimic its activ- 
ity in in vitro assays, we were unable to definitively assay the 
carboxypeptidase during myogenesis. However, to obtain a 
qualitative measure of the tubulin carboxypeptidase activity 
in vivo, we took advantage of the observation that when cells 
are treated with the MT-stabilizing drug, taxol (Gundersen 
et al., 1987), or when cytoskeletons are prepared by extrac- 
tion with the mild detergent, Brij 58 (our unpublished obser- 
vations), all cellular MTs are rapidly detyrosinated by the en- 
dogenous tubulin carboxypeptidase. When ~  ceils at each 
stage of myogenesis were treated with taxol or were extracted 
with Brij detergent, we observed similar time courses for the 
appearance of Glu tubulin in cellular MTs (data not shown). 
This suggests that the activity of the tubulin carboxypeptidase 
did not change dramatically during myogenesis. 
In contrast to the tubulin carboxypeptidase, the TTL has a 
unique enzyme activity that can be measured easily and ac- 
curately in crude cell extracts. When we examined TTL ac- 
tivity during myogenesis, we found that the enzyme activity 
increased significantly (,x,50%) by day 4  of differentiation 
and remained at this level throughout the remainder of myo- 
genesis (Fig 9). Accordingly, the increase we observed in the 
level of Glu tubulin during myogenesis cannot be attributed 
to alterations in TTL activity since an elevation in Glu tubu- 
lin level could be caused by a decrease, but not by an in- 
crease, in TTL activity. 
Discussion 
In this study, we have documented increases in the level of 
two alpha-tubulin posttranslational modifications during myo- 
genesis of cultured rat L~ cells. The level of tubulin detyro- 
sinated by the enzymatic removal of  its COOH-terminal tyro- 
sine increased dramatically during early myogenesis, before 
myoblast fusion. This was manifested as an increase in the 
number of MTs enriched in Glu tubulin in both prefusion 
myoblasts and multinucleated myotubes.  Significantly, the 
increase was detectable at even earlier myogenic stages than 
was muscle MHC, a standard marker of early myogenic dif- 
ferentiation. Thus, the increase in Glu MT levels represents 
one of the earliest detectable cytoskeletal alterations during 
myogenesis. It will be interesting to determine whether the 
change in Glu tubulin level we have observed requires new 
genetic input or is triggered solely by external factors-e.g., 
a change in the social interaction of the myoblasts. 
We also found that the levels of Ac tubulin, assayed either 
by immunoblots or immunofluorescence, increased dramati- 
cally during myogenesis. However, the increase in Ac tubulin 
differed from that of Glu tubulin, both in timing and pattern. 
Ac tubulin did not increase until after myoblast fusion had 
occurred, in contrast to the early increase of Glu tubulin we 
observed in myoblasts. Differences in timing of Ac and Glu 
tubulin increases have been reported previously; in fibro- 
blasts, in which the level of  posttranslational modification in- 
creased after recovery from drug treatment or cell division, 
it was Ac tubulin that reached its steady-state level more rap- 
idly than did Glu tubulin (Bulinski et al.,  1988). Although 
both modifications were frequently present on the same MTs 
in myotubes, Ac tubulin was usually enriched in MT seg- 
ments,  while Glu tubulin was  more uniformly distributed 
along the length of the MTs. Therefore, acetylation and dety- 
rosination of alpha-tubulin appear to be regulated separately 
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Figure 9.  TTL activity during I.~ myogenesis. TTL activity, ex- 
pressed as U-rain  -t-mg -~ extract protein and as a percentage of the 
activity in undifferentiated myoblasts (day 0).  See Materials and 
Methods for details of the assay; activities plotted are the mean 
+  SD from three experiments. 
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in differentiation. 
While our data support the idea that MT stabilization dur- 
ing myogenesis results in increased levels of Glu MTs, it is 
worthwhile to consider the three possible mechanisms that 
could lead to an increase in Glu MTs: (a) a change in the ac- 
tivity of one of the enzymes that carries out the reversible 
modification; (b) an induction of a tubulin gene whose pro- 
tein product lacks a  COOH-terminal tyrosine residue and 
possesses the COOH-terminal sequence ofGlu tubulin; or (c) 
an alteration in MT dynamics. Alterations in the level of the 
enzymes involved in the tyrosiuation/detyrosination cycle 
might be expected to contribute to the elevation in level of 
Glu tubulin that we have observed in myogenic cells. Tubulin 
carboxypeptidase cannot be readily assayed in cell extracts 
since its activity is mimicked by several other carboxypepti- 
dases and exopeptidases. However,  when we tested the "in 
vivo activity" of tubulin carboxypeptidase by treating cells 
with taxol or with Brij detergent, we did not see a dramatic 
change in tubulin carboxypeptidase activity during myogen- 
esis. The tubulin carboxypeptidase assays we performed are 
qualitative, and it is still possible that a quantitative change 
in the activity of tubulin carboxypeptidase contributes to the 
increased level of Glu tubulin that we observed in I~ cells 
undergoing myogenesis. Yet, even a quantitative change in 
carboxypeptidase activity could not explain our observation 
that only certain MTs in elongating myoblasts were detyrosi- 
hated (e.g., Fig. 4). When we measured the activity of the 
tyrosinating enzyme, TTL, we found that the activity in- 
creased during myogenesis. This was somewhat surprising, 
since the steady-state level of TTUs substrate (i.e., Glu tubu- 
lin) also increased during differentiation. However, we have 
also found a parallel increase in TTL activity and Glu tubulin 
during neurite outgrowth from PC-12  cells (Modesti,  N., 
and J. C. Bulinski, unpublished observations). Naturally, an 
increase in the activity of TTL during myogenesis could not 
cause an increase in Glu tubulin. That TTL activity increases 
concomitantly with Glu tubulin suggests that cells carefully 
regulate their level ofGlu tubulin. Webster et al. (1987a) mi- 
croinjected Glu tubulin into human fibroblasts and found that 
the injected Glu tubulin was tyrosinated rapidly. One could 
speculate that the apparent ability of cells to "buffer" their 
levels of Glu and Tyr tubulin may enable them to avoid some 
deleterious effect of excess Glu tubulin, especially in the cel- 
lular pool of protomer, which is maintained as almost 100% 
Tyr tubulin (Gundersen et al.,  1987). 
We have not examined the second possibility directly; how- 
ever, available evidence suggests that increased synthesis of 
a tubulin isoform that lacks a COOH-terminal tyrosine resi- 
due and terminates, instead, in a glutamic acid residue does 
not contribute greatly to the increased level of Glu MTs that 
we have observed. Only one of the six known mammalian 
genes for alpha-tubulin ends in a COOH-terminal glutamic 
acid rather than a tyrosine residue (Villasante et al., 1986). 
Differentiating mouse myogenic cells do express the alpha- 
tubulin isoform, called M alpha 4, that possesses a COOH- 
terminal glutamate residue, along with several other tubulin 
isotypes that possess a COOH-terminal tyrosine residue (Lewis 
and Cowan, 1988). Expression ofa gene analogous to M al- 
pha 4-tubulin in the rat I~ cells during myogenesis could 
contribute to the increase in Glu tubulin that we have ob- 
served. However, Lewis and Cowan found that, although the 
M alpha 4-tubulin mRNA is reasonably abundant, its pro- 
tein product is not. M alpha 4-tubulin was not detectable on 
immunoblots of extracts of mouse muscle cells at any stage 
of differentiation and was only weakly detectable in a subset 
of mouse myotubes examined in  immunofluorescence ex- 
periments (Lewis and Cowan, 1988).  In another study, Gu 
et al. (1988) demonstrated that, in HeLa cells transfected with 
the M alpha 4-tubulin gene, the M alpha 4-tubulin protein 
product was subject to posttranslational tyrosination. Thus, 
in our study of L6 cells, it is unlikely that the protein prod- 
uct of the rat analogue of the M alpha 4-tubulin gene, which 
would not be an abundant tubulin form and which would be 
subject to posttranslational tyrosination, contributes signifi- 
cantly to the increase in Glu tubulin we have observed. 
The third possibility, that increases in Glu tubulin result 
from a stabilization of some of the myoblast MTs, seems the 
most plausible. This notion was borne out by a direct demon- 
stration of the enhanced stability of MTs in myotubes and 
differentiating myoblasts toward nocodazole-induced depo- 
lymerization. Although the Glu MTs in prefusion myoblasts 
and in myotubes represent a stabilized subset of the total ar- 
ray, we do not yet know to what degree these MTs are stabi- 
lized. At a minimum, the Glu MTs must have persisted long 
enough to accumulate levels of Gin tubulin detectable with 
our Glu tubulin antibody. In fibroblasts and epithelial cells 
this minimum time is 20 min (Gundersen et al., 1987), and 
we have found a similar minimum time for Glu MT formation 
in L~ cells (our unpublished observations).  Nonetheless, it is 
likely that the Glu MTs in prefusion myoblasts and myotubes 
persist much longer. In fibroblasts and epithelial cells, most 
Glu MTs persist for at least 1 h, and a significant  number per- 
sist even longer (Webster et al., 1987b).  This is in contrast 
to the majority of cellular MTs (i.e., Tyr MTs), whose half- 
life has been measured to be 5-10 min (Schulze and Kirsch- 
ner, 1986). An upper limit on the type of stabilization event 
we envision in 1.6 cells is invoked by the experiments report- 
ext by Toyama et al. (1982). They showed that taxol treatment 
of myoblasts and myotubes, which presumably halted MT 
turnover completely, resulted in abnormal myogenesis and 
dissolution of mature myofibrils. Thus, at some point during 
myogenesis, it is likely that even the stable Glu MTs must be 
broken down. Independent measurements of the longevity of 
Glu MTs with the biotinylated tubulin technique (e.g., Web- 
ster et al., 1987b) should provide an answer to this interest- 
ing question. 
Although we have not determined the actual half-life of the 
stable MTs in differentiating muscle cells, it is interesting to 
note that this population of MTs appears to accumulate rela- 
tively slowly during the course of  myogenesis. When we first 
detect stable MTs in prefusion myoblasts, they represent a 
small subset of the total MT array (Figs. 2 and 4); later, after 
fusion has occurred, the array of stable MTs is virtually in- 
distinguishable from the total MT array (Fig. 2). This gradual 
accumulation of stable MTs may be mechanistically important 
for the cell to remodel its MT array. In fact, if all of the dy- 
namic MTs in the radial array present in myoblasts were rap- 
idly converted to stable MTs, it is difficult to imagine how 
the bipolar array characteristic of  myotubes could be generated. 
What is the function of the stabilized MTs in myogenesis? 
At least during the early, prefusion course of myogenesis the 
stable MTs seem to be involved in the alteration of myoblast 
cell shape. We found increasing numbers of Glu and, hence 
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usually distributed  parallel to the extended axis of the cell. 
The location of these stable MTs and the timing of their for- 
mation are consistent with a role in the elongation of the cells. 
MTs might not be limited to this putative  role in myoblast 
elongation; they might act in a different fashion during a sec- 
ond, later phase of myogenesis.  Several studies have shown 
that MTs are necessary for the proper assembly and align- 
ment of myofibrils (e.g., Toyama et al.,  1982).  Myofibrillo- 
genesis occurs in myotubes, so it is possible that the postfu- 
sion increase in Ac MTs is involved in this later MT function. 
In a completely different system, namely, the initiation of 
fibroblast migration in experimentally wounded monolayers, 
we found that stable, Glu MTs were generated specifically 
in the direction of impending cell migration (Gundersen and 
Bulinski,  1988).  Thus, for both myogenesis and cell migra- 
tion, a similar stabilization of MTs occurs during  the time 
that  the cells are altering  their morphology.  In fact,  both 
results support a general model of MT-based morphogenesis 
recently proposed by Kirschner and Mitchison  (1986).  In 
this model, the "ground state" of MTs is taken to be a dynamic 
one in which MTs turn over rapidly.  To initiate  a morpho- 
genetic event, MTs are selectively stabilized in a distinct area 
(or multiple areas) of the cell. Because of the rapid turnover 
of the remaining dynamic MTs, this generates an asymmetry 
in the MT array that can, theoretically, be used to effect a 
morphological change. While details of this model remain to 
be established, such as the nature of the stabilization  process 
and the mechanism by which some MTs are selected while 
others are neglected,  it appears  that the general features  of 
the model can be used successfully to describe the behavior 
of MTs in two divergent morphogenetic processes, only one 
of which constitutes a terminal differentiation. 
A  significant question that remains is how the MTs, spe- 
cifically the stable MTs, actually contribute to cellular mor- 
phogenesis. Previous work points to two possibilities. First, 
a large body of pharmacological evidence has accumulated 
demonstrating that MTs lend structural integrity to cells (for 
review see Dustin,  1984).  This structural  reinforcement of 
the cells is presumably due to the limited deformability of 
the MT fiber itself or to secondary interactions  of the MT 
with other cytoskeletal elements. According to this view, the 
role played by MT stabilization would be to enhance the struc- 
tural rigidity of the cell along the particular  axis adopted by 
the stabilized MTs. The second possibility of note is that MTs 
play a more active, albeit indirect, role by serving as tracks 
supporting the movement of organelles or vesicles. In partic- 
ular, if a significant proportion of the membrane precursors 
necessary for membrane expansion traveled along MTs, then 
polarized membrane addition leading to cell elongation would 
occur when MTs were stabilized in a particular  area of the 
cell. An attractive  feature of this model is that it suggests a 
function for the posttranslational  modifications of tubulin that 
accumulate on stable MTs: the modifications, by biochemi- 
cally differentiating  stable MTs  from dynamic MTs, could 
serve  as  signals  for the  enhanced transport  of membrane 
vesicles on stable MTs.  While direct support  for this MT- 
based membrane growth model has not yet been obtained, 
evidence has been obtained for both localized stabilization 
of MTs (Gundersen and Bulinski, 1988) and vectorial mem- 
brane insertion (Betgmann et al., 1983) in the case of directed 
fibroblast motility. That the membrane precursors are actu- 
ally traveling along MTs and that the selective stabilization 
of MTs results in vectorial insertion of membrane precursors 
both remain  to be established.  The data we have presented 
here indicate that myogenesis will be a useful system for fur- 
ther study of the role of MTs in cellular morphogenesis. 
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